Journal article

Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Rees, M. G., & Gloyn, A. (2014). Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour? Diabetes Technology and Therapeutics, 16(SUPPL. 1), S-119-S-127.

MLA Style

Rees, M. G., and A. Gloyn. “Small Molecular Glucokinase Activators: Has Another New Anti-Diabetic Therapeutic Lost Favour?” Diabetes Technology and Therapeutics, vol. 16, no. SUPPL. 1, 2014, pp. S-119-S-127.

Chicago Style

Rees, MG, and A Gloyn. 2014. “Small Molecular Glucokinase Activators: Has Another New Anti-Diabetic Therapeutic Lost Favour?” Diabetes Technology and Therapeutics 16 (SUPPL. 1): S-119-S-127.
Share
Print

Access Document

Publisher copy:: 10.1089/dia.2014.1514

Authors

+ Rees, MG More by this author

Role:: Author

+ Gloyn, A More by this author

Institution:: University of Oxford
Division:: MSD
Department:: RDM
Sub department:: OCDEM
Role:: Author

Journal:: Diabetes Technology and Therapeutics More from this journal
Volume:: 16
Issue:: SUPPL. 1
Pages:: S-119-S-127
Publication date:: 2014-01-01
DOI:: 10.1089/dia.2014.1514
EISSN:: 1557-8593
ISSN:: 1520-9156

Language:: English
Pubs id:: pubs:450163
UUID:: uuid:ffb05e09-ac91-45a4-bf96-195523f4d84c
Local pid:: pubs:450163
Source identifiers:: 450163
Deposit date:: 2014-08-11

Terms of use

Copyright date:: 2014

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP